CoChat

A paired comparison between glioblastoma “stem cells” and differentiated cells

Open access
Schneider, Matthias, Ströbele, Stephanie, Nonnenmacher, Lisa, Siegelin, Markus D., Tepper, Melanie, Stroh, Sebastien, Hasslacher, Sebastian, Enzenmüller, Stefanie, Strauss, Gudrun, Baumann, Bernd, Karpel‐Massler, Georg, Westhoff, Mike‐Andrew, Debatin, Klaus‐Michael, Halatsch, Marc‐Eric · 2016 · International Journal of Cancer
Cited by 51

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Cancer stem cells (CSC) have been postulated to be responsible for the key features of a malignancy and its maintenances, as well as therapy resistance, while differentiated cells are believed to make up the rapidly growing tumour bulk. It is therefore important to understand the characteristics of those two distinct cell populations in order to devise treatment strategies which effectively target both cohorts, in particular with respect to cancers, such as glioblastoma. Glioblastoma is the most common primary brain tumour in adults, with a mean patient survival of 12–15 months. Importantly, therapeutic improvements have not been forthcoming in the last decade. In this study we compare key features of three pairs of glioblastoma cell populations, each pair consisting of stem cell‐like and differentiated cells derived from an individual patient. Our data suggest that while growth rates and expression of key survival‐ and apoptosis‐mediating proteins are more similar according to differentiation status than genetic similarity, we found no intrinsic differences in response to standard therapeutic interventions, namely exposure to radiation or the alkylating agent temozolomide. Interestingly, we could demonstrate that both stem cell‐like and differentiated cells possess the ability to form stem cell‐containing tumours in immunocompromised mice and that differentiated cells could potentially be dedifferentiated to potential stem cells. Taken together our data suggest that the differences between tumour stem cell and differentiated cell are particular fluent in glioblastoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.29908

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Schneider, M., Ströbele, S., Nonnenmacher, L., Siegelin, M. D., Tepper, M., Stroh, S., Hasslacher, S., Enzenmüller, S., Strauss, G., Baumann, B., Karpel‐Massler, G., Westhoff, M., Debatin, K., & Halatsch, M.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2015-11-17
Volume
138
Issue
7
Pages
1709-1718
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1864887926
Cited by
51
References
3
FWCI
2.61
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.